Compounded semaglutide faces evolving FDA regulations
As with other incretin-based therapies, the most commonly reported adverse effects of retatrutide in Phase 2 trials were gastrointestinal in nature (Jastreboff et al., NEJM , 2023)
Dont panic just reach out to your healthcare provider immediately
Starting with higher purity extends the window of therapeutic reliability
Background Alcohol consumption is widespread globally, but the resulting hangovers can lead to discomfort, such as headaches, dizziness, and fatigue, significantly impacting daily activities like work performance and driving
Microdosing GLP-1s: The bottom line While microdoses of GLP-1s havent been clinically tested, microdosing has the potential to help people who struggle with access, cost, or side effects